Targeting in photodynamic therapy and photo-imaging

Optics and Photonics News

Volumn 14, Issue 8, 2003, Pages 36-43

  Pogue, Brian W ^a,b   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; CELLS; FLUORESCENCE; IMAGING TECHNIQUES; IRRADIATION; OPTICAL SYSTEMS; TISSUE; TUMORS;

OPTICAL AGENTS;

PHOTODYNAMIC THERAPY;

EID: 0041929637     PISSN: 10476938     EISSN: None     Source Type: Trade Journal    
DOI: 10.1364/OPN.14.8.000036     Document Type: Review

References (33)

1. Hasan, T., et al., Photodynamic Therapy of Cancer, Chapt. 40 in Holland-Frei Cancer Medicine, 6th Ed. BC Decker, 2003.
2. Selkin, B., et al., In vivo confocal microscopy in dermatology. Dermatol. Clin., 2001.19(2), 369-77.
3. Oheim, M., et al., Two-photon microscopy In brain tissue: parameters Influencing the Imaging depth, J. Neurosci. Meth., 2001. 111(1), 29-37.
4. Rajadhyaksha, M., et al., Confocal Examination of Nonmelanoma Cancers in Thick Skin Excisions to Potentially Guide Mohs Micrographic Surgery Without Frozen Histopathology. J. Invest. Derm., 2001. 117, 1137-43.
5. Fujimoto, J.G., et al., Optical coherence tomography: an emerging technology for biomedical Imaging and optical biopsy. Neoplasia, 2000, 2(1-2), 9-25.
6. Jacques, S.L., J.C. Ramella-Roman, and K. Lee, Imaging skin pathology with polarized light. J. Biomed. Opt., 2002. 7, 329-40.
7. Wilson, B.C., et al., The optical absorption and scattering properties of tissues in the visible and nearinfrared wavelength range, in Light in Biology and Medicine, M. Douglas, DallAcqua, Editor. 1988, Plenum Publ., 45-52.
8. Arridge, S.R., Optical tomography in medical imaging. Inverse Problems, 1999. 15(2), R41-R93.
9. Pogue, B.W., et al., Quantitative Hemoglobin Tomography with Diffuse Near-Infrared Spectroscopy: Pilot Results in the Breast. Radiology, 2001. 218(1), 261-6.
10. Ntziachristos, V. and B. Chance, Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Research, 2001. 3(1), 41-6.
11. Dehghani, H., Pogue, B. W., Poplack, S. P., Paulsen, K. D., "Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results, " Applied Optics, 2003, 42(1), 135-45.
12. Hawrysz, D.J. and E.M. Sevick-Muraca, Developments toward diagnostic breast cancer imaging using nearinfrared optical measurements and fluorescent contrast agents. Neoplasia, 2000. 2(5), 388-417.
13. Dougherty, T.J., et al., Photodynamic therapy. J. Nat. Cancer Inst., 1998. 90(12), 889-905.
14. Hasan, T., A.C.E. Moor, and B. Ortel, Photodynamic Therapy of Cancer, in Cancer Med. 1999, Williams & Wilkins: Baltimore, p. 489-501.
15. Bonnett, R., Photosensitizers of the Porphyrin and Phthalocyanine Series for Photodynamic Therapy. Chem Soc Rev, 1995. 24(1), 19-33.
16. Levy, J.G., Photosensitizers in photodynamic therapy. Sem. Oncol., 1994. 21 (6 Suppl 15), 4-10.
17. Krinick, N.L., et al., A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light, Journal of Biomaterials Science, Polymer Edition, 1994. 5(4), 303-24.
18. Weissleder, R. and U Mahmood, Molecular imaging. Radiology., 2001. 219(2), 316-33.
19. Weissleder, R., et al., In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnology., 1999. 17(4), 375-8.
20. Weissleder, R., Scaling down imaging: molecular mapping of cancer in mice. Nature Reviews. Cancer., 2002. 2(1), 11-8.
21. Del Governatore, M., et al., Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1 A chlorin(e6) immunoconjugate. Cancer Research, 2000. 60(15), 4200-5.
22. Soukos, N.S., et al., Epidermal growth factor receptortargeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Research., 2001. 61(11), 4490-6.
23. Savellano, M.D. and T. Hasan, PECylated BPD Verteporfin Photosensitizer lmmunoconjugates Directed Against the Epidermal Growth Factor Receptor. Photochem. Photobiol., 2003, 77(4), 431-9.
24. Morgan, J. and A.R. Oseroff, Mitochondria-based photodynamic anti-cancer therapy. Advanced Drug Delivery Reviews., 2001. 49(1-2), 71-86.
25. Schmidt-Erfurth, U., et al., Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmol., 1993. 101(12), 1953-61.
26. Kessel, D. and Y. Luo, Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Diff., 1999. 6(1), 28-35.
27. Pogue, B.W., et al., Photodynamic therapy of the RIF-1 tumor with verteporfin causes enhanced radiation sensitivity. Cancer Res., 2003. 63, 1025-33.
28. Kennedy, J.C. and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol., 1992. 14(4), 275-92.
29. Lange, N., et al., Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. British Journal of Cancer, 1999. 80(1-2), 185-93.
30. Stummer, W., et al., Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J. Neurosurg., 2000. 93, 1003-13.
31. Ortel, B., et al., Differentiation enhances ALA-dependent photodynamic therapy in LNCaP prostate cancer cells. Brit. J. Cancer, 2002. 87(11), 1321-7.
32. Berg, K., et al., Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Research., 1999. 59(6), 1180-3.
33. Selbo, P.K., et al., In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. International Journal of Cancer., 2001, 92(5), 761-6.